3-iodobenzylguanidine has been researched along with Basal Ganglia Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dillmann, U; Dogan, S; Ezziddin, S; Fassbender, K; Schaefer-Schuler, A; Schubert, E; Spiegel, J | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Basal Ganglia Diseases
| Article | Year |
|---|---|
MIBG scintigraphy of the major salivary glands in progressive supranuclear palsy and corticobasal degeneration.
Topics: 3-Iodobenzylguanidine; Aged; Basal Ganglia Diseases; Female; Humans; Male; Middle Aged; Parotid Gland; Radionuclide Imaging; Radiopharmaceuticals; Submandibular Gland; Supranuclear Palsy, Progressive | 2019 |